山东痛风病中医怎么治疗(山东有痛风石就一定痛风) (今日更新中)

SAN FRANCISCO, March 7 (Xinhua) -- The world's leading hard rive producer Western Digital Corp. on Monday announced that it has agreed to buy Hitachi Ltd.'s hard disk drive unit for about 4. 3 billion U.S. dollars, a move that will create a dominant player in the industry.Western Digital said that it plans to acquire Hitachi Global Storage Technologies, a wholly-owned subsidiary of Hitachi Ltd., in cash and stock.The proposed combination will result in a customer-focused storage company with the industry's broadest product lineup backed by a rich technology portfolio, Western Digital said.According to their agreement, the resulting company will retain the Western Digital name and remain headquartered in Irvine in the U.S. state of California.The transaction has been approved by the board of directors of each company and is expected to close during the third quarter of 2011.With the purchase, Western Digital will claim 49.6 percent share of global hard disk drive unit shipments based on latest quarterly statistics, compared to 29.4 percent for Seagate Technology LLC, the industry's No. 2 supplier, research firm iSuppli pointed out.The deal will give Western Digital a lead of 20.2 percentage points over Seagate, up from a mere 2 points without the acquisition, iSuppli said in a research note released Monday.The acquisition will also allow Western Digital to enter the critical enterprise hard disk drive segment, where it currently is only a marginal player.Analysts believed that the purchase might be a consequence of declining hard disk drive shipments, which are being impacted by the rising sales of tablet computers, which don't use hard disk drives and are cutting into the sales of mobile PCs, a major market for hard drives."Amid weaker industry conditions, organic sales growth is more difficult to achieve, prompting hard disk drive suppliers to engage in acquisitions to gain market share," iSuppli noted.

BEIJING, March 11 (Xinhuanet) --Women who have a cup or more of coffee everyday may reduce their risk of stroke by as much as 25 percent, according to a new study in the Journal Stroke Thursday. This study, led by Swedish researcher Susanna Larsson of the Karolinska Institute in Stockholm, followed more than 34,000 Swedish women aged 49 to 83 who were free of heart disease. After 10-year of follow-up, there were 1,680 strokes, and the study found that those who drank at least one cup of coffee each day had a 22 to 25 percent lowered risk of stroke, compared with women who drank less.The study further suggested coffee can help prevent cognitive decline and can boost vision and heart health. It is also related to a reduced risk of liver cancer."We used to worry that (coffee) raises blood pressure and causes increased heart rate, but it appears to be less risky than we thought," said physician Claudette Brooks, spokesperson for the American Stroke Association. Now, exactly what it is about coffee that may lower stroke risk is unknown. But the researchers speculated that coffee might reduce inflammation, lower oxidative stress and help make the body more responsive to insulin.However, some experts kept skeptical about the real impact coffee would have on reducing the incidence of stroke."The problem with this type of study is that there are too many factors unaccounted for and association does not prove causality," Dr Larry B. Goldstein, director of the Duke Stroke Center at Duke University Medical Center said."Subjects were asked about their past coffee consumption in a questionnaire and then followed over time. There is no way to know if they changed their behavior," Goldstein added.In any case, the good news for coffee junkies is that at least drinking coffee don't increase women's risk of stroke.

NICOSIA, March 8 (Xinhua) -- Cypriot geneticists have reported a non-invasive Down's Syndrome test that could possibly replace the risky amniocentesis procedure now in use.A team of researchers at the Cyprus Institute of Neurology and Genetics reported in Nature Medicine journal that the new test involves only a small quantity of blood taken from the mother's arm, which is analyzed to detect DNA differences between the mother and the fetus.Philippos Patsalis, medical director of the institute, said Tuesday the new method eliminates dangers involved with amniocentesis testing, which involves sampling amniotic fluid by inserting a hollow needle into the mother's uterus.At present, only women belonging to high risk groups, including older women, are tested for Down's Syndrome, which is the most common genetic cause of mental retardation.Patsalis, who led the study, said the new method would be made available to the medical community after clinical tests are concluded world-wide on 1,000 women within two years.

BEIJING, Jan. 24 (Xinhua) -- China's top economic planner said Monday that price supervision and control measures have achieved steady progress with 2010's Consumer Price Index, slightly exceeding the target ceiling by 0.3 percentage points to hit 3.3 percent.To rein in soaring commodities prices, joint efforts have been made to manage inflation expectations, promote production, ensure supplies and strengthen price supervision in 2010, said the National Development and Reform Commission (NDRC) in an online statement.Prices of necessities accelerating during the second half of 2010 have been contained with vegetable prices down 9.4 percent in December from the previous month last year, it said.Further, prices of edible vegetable, pork, egg, sugar,liquefied petroleum gas and clothing also decreased significantly in December month on month, the statement said.To cope with rising prices beginning in July 2010, especially prices of basic supplies, the central government promptly introduced joint inter-ministerial meetings to discuss price controls among 17 ministries and ordered local governments to establish the same mechanism, it noted.Local governments have worked on improving agricultural facilities, especially in south China's Hainan province, to increase vegetables supplies for northern cities over the past year, the statement said.The statement forecasts that vegetable planting areas in 2010's autumn and winter will increase 530,000 hectares year on year, sending output to 337 million tonnes.To ensure production and supply, departments have worked to reduce fertilizer exports and promote links between production areas and purchasing areas, it added.Further, relevant authorities also took measures to stabilize prices of electricity and coal, and to ensure smooth transportation of agricultural produce.Authorities also granted temporary subsidies and raised basic wages and minimum living subsidies for urban and rural residents to guarantee people's daily life.

WASHINGTON, March 4 (Xinhua) -- New data suggest that the epilepsy drug Topamax (topiramate) and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and Drug Administration (FDA) said Friday in a statement.Before prescribing topiramate, approved to treat certain types of seizures in people who have epilepsy, health care professionals should warn patients of childbearing age about the potential hazard to the fetus if a woman becomes pregnant while using the drug, the FDA said.Topiramate also is approved to prevent migraine headaches, but not to relieve the pain of migraines."Health care professionals should carefully consider the benefits and risks of topiramate when prescribing it to women of childbearing age," said Russell Katz, director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research. "Alternative medications that have a lower risk of birth defects should be considered."Cleft lip and cleft palate, collectively called oral clefts, are birth defects that occur when parts of the lip or palate do not completely fuse together early in the first trimester of pregnancy, a time when many women do not know they are pregnant.The defects range from a small notch in the lip to a groove that runs into the roof of the mouth and nose, possibly leading to problems with eating, talking, and to ear infections. Surgery often is performed to close the lip and palate and most children do well after treatment.Data from the North American Antiepileptic Drug (AED) Pregnancy Registry indicate an increased risk of oral clefts in infants exposed to topiramate during the first trimester of pregnancy. Infants exposed to topiramate as a single therapy experienced a 1.4 percent prevalence of oral clefts, compared with a prevalence of 0.38 percent - 0.55 percent in infants exposed to other antiepileptic drugs.Infants of mothers who did not have epilepsy and were not being treated with other antiepileptic drugs had a prevalence of 0.07 percent. Similar data from the United Kingdom Epilepsy and Pregnancy Register supported the North American AED Pregnancy Registry data.According to the FDA, before starting topiramate, pregnant women and women of childbearing potential should discuss other treatment options with their health care professional.

来源：资阳报